Column Group II GP, LP, 10% Owner at Immune Design Corp. (IMDZ), bought 800,000 shares at $6.25 ($5.0M) on 2016-09-20, disclosed to the SEC on 2016-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| NGM | BUY | 2020-08-03 | $13K | — | Filing → |
| NGM | BUY | 2019-07-15 | $885K | — | Filing → |
| NGM | BUY | 2019-05-09 | $804K | — | Filing → |